–
Pliant Therapeutics Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−97.5
FY22:
−127
FY23:
−184
FY24:
−228
FY25:
−156
(positive)
Change from FY21 to FY25
millions USD
FY21:
−95.7
FY22:
−121
FY23:
−158
FY24:
−205
FY25:
−143
(positive)
Change from FY21 to FY25
millions USD
FY21:
−97.3
FY22:
−123
FY23:
−161
FY24:
−210
FY25:
−149
(positive)
Change from FY21 to FY25
millions USD
FY21:
−97.3
FY22:
−123
FY23:
−161
FY24:
−210
FY25:
−149
All amounts in millions USD